File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1093/neuonc/noaa222.196
- Find via
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Epidemiology Study of Uncommon Childhood Brain Tumors in Asian Children
Title | Epidemiology Study of Uncommon Childhood Brain Tumors in Asian Children |
---|---|
Authors | |
Keywords | brain tumors craniopharyngioma ependymoma germ cell tumor choroid plexus |
Issue Date | 2020 |
Publisher | Oxford University Press. The Journal's web site is located at https://academic.oup.com/neuro-oncology |
Citation | The 19th International Symposium on Pediatric Neuro-Oncology (ISPNO) 2020, Karuizawa, Japan, 13-16 December 2020. In Neuro-Oncology, 2020, v. 22 n. Suppl. 3, p. iii320 How to Cite? |
Abstract | Our local registry identified 656 brain tumours from Jan 1999 to Dec 2018, (incidence: 29.8/yr/million). Other from Glioma, Medulloblastoma/PNET, Germ Cell tumours, Ependymoma, the remaining rarer tumours accounted for 18% (n=118). The 7 more common groups are: craniopharyngioma(n=28); ATRT(n=18); choroid plexus papilloma/CA(n=12); Ganglioglioma(n=11); ETMR(n=7); DNET(n=7); meningioma(n=6). Their respective incidences are 1.27; 0.81; 0.55; 0.5; 0.32; 0.32 0.27/yr/million. For craniopharyngioma, M:F=15:13 and median age was 7.4yrs (2mons-16.5yrs). 12/28 children had surgery alone and 13/28 had focal RT post-surgery with better outcome. 3 underwent intra-cystic interferon-beta also stable. For ATRT, M:F=7:8 and median age was 2.3yrs (4mos-14.2yrs). 2 had metastatic disease and 7/18 patients remained alive. For choroid plexus tumours, there were 7 papilloma, 2 atypia and 3 carcinoma. M:F=5:6 and median age was 1.5yrs (4mos-14yrs). All papilloma, 1/2 atypia and 1/3 carcinoma survived. For ganglioglioma, M:F=7:4 with median age of 5.5yrs (5mos-13.2yrs). They commonly presented with seizure and only one died (brainstem primary). The ETMR includes ependymoblastoma and medulloepithelioma, they had quite different clinical characteristics and outcome. 6/7 DNET had convulsion and M:F=6:1. Median age was 11.5yrs (2.66-14yrs). They all survived even if incompletely resected. For meningioma, 1/6 had germline mutation of NF-2 gene. M:F=3:3 and onset was >8yrs except the NF-2 patient. All survived but the NF-2 had multiple recurrences. 4 patients developed secondary meningioma due to irradiation but they were >18yrs so excluded. In summary, rarer forms of childhood brain tumours only accounted for <20% of all brain tumours and they had diverse presenting features and outcome. |
Description | Poster presentation - Section: Epidemiology - no. EPID-10 |
Persistent Identifier | http://hdl.handle.net/10722/287797 |
ISSN | 2023 Impact Factor: 16.4 2023 SCImago Journal Rankings: 6.348 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, GCF | - |
dc.contributor.author | Liu, APY | - |
dc.contributor.author | Shing, MMK | - |
dc.contributor.author | Ku, DTN | - |
dc.date.accessioned | 2020-10-05T12:03:26Z | - |
dc.date.available | 2020-10-05T12:03:26Z | - |
dc.date.issued | 2020 | - |
dc.identifier.citation | The 19th International Symposium on Pediatric Neuro-Oncology (ISPNO) 2020, Karuizawa, Japan, 13-16 December 2020. In Neuro-Oncology, 2020, v. 22 n. Suppl. 3, p. iii320 | - |
dc.identifier.issn | 1522-8517 | - |
dc.identifier.uri | http://hdl.handle.net/10722/287797 | - |
dc.description | Poster presentation - Section: Epidemiology - no. EPID-10 | - |
dc.description.abstract | Our local registry identified 656 brain tumours from Jan 1999 to Dec 2018, (incidence: 29.8/yr/million). Other from Glioma, Medulloblastoma/PNET, Germ Cell tumours, Ependymoma, the remaining rarer tumours accounted for 18% (n=118). The 7 more common groups are: craniopharyngioma(n=28); ATRT(n=18); choroid plexus papilloma/CA(n=12); Ganglioglioma(n=11); ETMR(n=7); DNET(n=7); meningioma(n=6). Their respective incidences are 1.27; 0.81; 0.55; 0.5; 0.32; 0.32 0.27/yr/million. For craniopharyngioma, M:F=15:13 and median age was 7.4yrs (2mons-16.5yrs). 12/28 children had surgery alone and 13/28 had focal RT post-surgery with better outcome. 3 underwent intra-cystic interferon-beta also stable. For ATRT, M:F=7:8 and median age was 2.3yrs (4mos-14.2yrs). 2 had metastatic disease and 7/18 patients remained alive. For choroid plexus tumours, there were 7 papilloma, 2 atypia and 3 carcinoma. M:F=5:6 and median age was 1.5yrs (4mos-14yrs). All papilloma, 1/2 atypia and 1/3 carcinoma survived. For ganglioglioma, M:F=7:4 with median age of 5.5yrs (5mos-13.2yrs). They commonly presented with seizure and only one died (brainstem primary). The ETMR includes ependymoblastoma and medulloepithelioma, they had quite different clinical characteristics and outcome. 6/7 DNET had convulsion and M:F=6:1. Median age was 11.5yrs (2.66-14yrs). They all survived even if incompletely resected. For meningioma, 1/6 had germline mutation of NF-2 gene. M:F=3:3 and onset was >8yrs except the NF-2 patient. All survived but the NF-2 had multiple recurrences. 4 patients developed secondary meningioma due to irradiation but they were >18yrs so excluded. In summary, rarer forms of childhood brain tumours only accounted for <20% of all brain tumours and they had diverse presenting features and outcome. | - |
dc.language | eng | - |
dc.publisher | Oxford University Press. The Journal's web site is located at https://academic.oup.com/neuro-oncology | - |
dc.relation.ispartof | Neuro-Oncology | - |
dc.relation.ispartof | The 19th International Symposium on Pediatric Neuro-Oncology (ISPNO) 2020 | - |
dc.subject | brain tumors | - |
dc.subject | craniopharyngioma | - |
dc.subject | ependymoma | - |
dc.subject | germ cell tumor | - |
dc.subject | choroid plexus | - |
dc.title | Epidemiology Study of Uncommon Childhood Brain Tumors in Asian Children | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Chan, GCF: gcfchan@hku.hk | - |
dc.identifier.email | Liu, APY: apyliu@hku.hk | - |
dc.identifier.authority | Chan, GCF=rp00431 | - |
dc.identifier.authority | Liu, APY=rp01357 | - |
dc.description.nature | abstract | - |
dc.identifier.doi | 10.1093/neuonc/noaa222.196 | - |
dc.identifier.hkuros | 314992 | - |
dc.identifier.volume | 22 | - |
dc.identifier.issue | Suppl. 3 | - |
dc.identifier.spage | iii320 | - |
dc.identifier.epage | iii320 | - |
dc.publisher.place | United States | - |
dc.identifier.issnl | 1522-8517 | - |